Retrospective Study
Copyright ©The Author(s) 2025.
World J Psychiatry. Jul 19, 2025; 15(7): 106023
Published online Jul 19, 2025. doi: 10.5498/wjp.v15.i7.106023
Table 1 Baseline demographic and clinical characteristics
Characteristic
Study group (n = 60)
Control group (n = 60)
P value
Age (year), mean ± SD71.3 ± 5.270.8 ± 5.50.65
Gender (male/female)34/2632/280.78
BMI (kg/m2)23.5 ± 2.823.8 ± 2.60.54
ASA classification distributionI: 10, II: 30, III: 20I: 12, II: 32, III: 160.89
Tumor stagingI: 10, II: 20, III: 20, IV: 10I: 12, II: 22, III: 18, IV: 80.92
Comorbidities (n)30280.73
Smoking history (yes/no)20/4018/420.81
Alcohol consumption (yes/no)15/4512/480.76
Hypertension (yes/no)25/3523/370.85
Diabetes mellitus (yes/no)12/4810/500.79
Previous surgery (yes/no)10/508/520.71
Family history of cancer (yes/no)15/4513/470.82
Chemotherapy history (yes/no)5/553/570.75
Radiotherapy history (yes/no)3/572/580.83
Table 2 Enhanced recovery indicators
Indicator
Study group (n = 60)
Control group (n = 60)
P value
Time to first flatus (hours)48.3 ± 6.262.5 ± 7.80.002
Time to ambulation (hours)28.4 ± 4.238.6 ± 5.10.001
Length of hospital stay (days)5.2 ± 1.17.4 ± 1.30.003
Postoperative pain score (0-10)3.1 ± 1.24.5 ± 1.50.004
Time to first diet (hours)36.2 ± 5.048.7 ± 6.30.001
Postoperative nausea and vomiting (yes/no)10/5020/400.012
Postoperative infection rate (%)5.0 ± 2.210.0 ± 3.10.021
Postoperative complications (n)8150.034
Patient satisfaction score (0-10)8.5 ± 1.07.0 ± 1.20.001
Table 3 Anxiety and depression scores
Indicator
Study group (n = 60)
Control group (n = 60)
P value
Anxiety score (mean ± SD)5.2 ± 1.47.8 ± 1.60.001
Depression score (mean ± SD)4.8 ± 1.27.1 ± 1.50.001
Patients with clinically significant anxiety (HAD score ≥ 7) (%)15.0% (9/60)35.0% (21/60)0.008
Patients with clinically significant depression (HAD score ≥ 7) (%)13.3% (8/60)31.7% (19/60)0.012
FOP score (mean ± SD)3.5 ± 1.05.0 ± 1.20.002
FAB score (mean ± SD)2.8 ± 0.94.2 ± 1.10.003
Psychological resilience score (mean ± SD)7.5 ± 1.55.8 ± 1.40.001
PostopQRS score (mean ± SD)85.2 ± 10.372.4 ± 12.10.001
Table 4 Inflammatory response analysis of inflammatory markers
Inflammatory marker
Study group (n = 60)
Control group (n = 60)
P value
IL-6 (pg/mL)42.3 ± 8.568.7 ± 12.4< 0.001
TNF-α (pg/mL)28.4 ± 5.645.2 ± 8.9< 0.001
CRP (mg/L)38.5 ± 7.262.4 ± 11.3< 0.001
IL-1β (pg/mL)12.5 ± 3.418.7 ± 4.50.002
IL-10 (pg/mL)15.2 ± 2.810.5 ± 2.10.001
MCP-1 (pg/mL)20.3 ± 4.228.6 ± 5.80.003
IFN-γ (pg/mL)9.8 ± 2.314.5 ± 3.70.004
S100A8 (ng/mL)1.2 ± 0.32.1 ± 0.50.001
Table 5 Sleep quality assessment
Indicator
Study group (n = 60)
Control group (n = 60)
P value
Global PSQI score (mean ± SD)5.2 ± 1.37.8 ± 1.80.002
Postoperative morphine equivalent consumption (mg)15.3 ± 3.223.6 ± 4.50.001
Sleep latency (minutes)20.4 ± 5.630.2 ± 7.10.003
Total sleep time (hours)6.8 ± 1.25.4 ± 1.00.001
Sleep efficiency (%)85.2 ± 6.372.4 ± 7.80.001
Sleep disturbances (n)12240.004
Use of sleep medication (yes/no)5/5515/450.012
Daytime dysfunction (n)8180.015
ESS score (mean ± SD)4.5 ± 1.26.8 ± 1.50.001
Table 6 Multivariate analysis of postoperative anxiety and depression
Risk factor
Variable
OR (95%CI)
P value
Postoperative anxiety (HAD-A ≥ 7)PH + GDFT intervention0.38 (0.24-0.62)0.001
Age ≥ 75 years1.85 (1.32-2.59)0.003
IL-6 levels at 24 hours (pg/mL)1.42 (1.18-1.71)0.002
PSQI > 52.13 (1.56-2.91)< 0.001
Postoperative complications2.45 (1.73-3.46)< 0.001
Postoperative pain score (NRS)1.25 (1.05-1.48)0.012
Duration of surgery (≥ 120 minutes)1.60 (1.10-2.33)0.015
Postoperative depression (HAD-D ≥ 7)PH + GDFT intervention0.41 (0.26-0.65)0.001
Age ≥ 75 years1.78 (1.25-2.53)0.002
IL-6 levels at 24 hours (pg/mL)1.35 (1.12-1.63)0.003
PSQI > 52.05 (1.48-2.84)< 0.001
Postoperative complications2.30 (1.60-3.33)< 0.001
Postoperative pain score (NRS)1.30 (1.08-1.56)0.007
Duration of surgery (≥ 120 minutes)1.55 (1.08-2.22)0.018